Background/Aims: Thickening and reduplication of the tubular basement membrane has been reported as an early event in diabetic nephropathy. The aim of the work outlined here was to examine the effects and mechanisms involved in the modulation of renal proximal tubular type-IV collagen and fibronectin turnover by glucose. Methods: The effect of glucose on type-IV collagen and fibronectin generation was studied by exposure of primary cultures of human renal proximal tubular cells (HPTC) to elevated D-glucose concentrations. Subsequently the mechanism of modulation of fibronectin generation was examined in a polarised system utilising the porcine proximal tubular cell line LLC-PK1 grown on porous tissue culture inserts. Results: Incubation of confluent growth-arrested HPTC with 25 mMD-glucose led to the accumulation of both type-IV collagen and fibronectin. This increase was not dependent on new gene transcription for either protein. Exposure of HPTC to 25 mMD-glucose also led to the induction of tissue inhibitor of metalloproteinases (TIMP-1 and TIMP-2) and also gelatinase A. There was, however, a net decrease in overall gelatinolytic activity. Incubation of confluent monolayers of LLC-PK1 cells grown on tissue culture inserts with 25 mMD-glucose on either their apical or basolateral aspect led to fibronectin accumulation seen only in the basolateral compartment. Under these experimental conditions, we can demonstrate polyol pathway activation, and furthermore the increase in fibronectin concentration in response to glucose was inhibited by the aldose reductase inhibitor sorbinil. Fibronectin accumulation was also demonstrated following both apical and basolateral addition of 1 mM sorbitol, but not following the addition of 25 mM galactose to either aspect of the cells. Conclusions: These data demonstrate that the glucose-induced accumulation of type-IV collagen and fibronectin was associated with alterations in the degradative pathway of these matrix components. In addition fibronectin generation in response to glucose was non-polar in terms of application of glucose, but polar in terms of fibronectin accumulation. The mechanisms of glucose-induced modulation of fibronectin were mediated by polyol pathway activation, and more specifically related to the metabolism of sorbitol to fructose.

1.
Mauer SM, Steffes MW, Ellis EE, Sutherland DER, Brown DM, Goetz FC: Structural-functional relationships in diabetic nephropathy. J Clin Invest 1984;74:1143–1155.
2.
Ihm CG, Lee GSL, Nast CC, Artishevsky A, Guillermo R, Levin PS, Glassock RJ, Adler SG: Early increased renal procollagen α1 (IV) mRNA levels in streptozotocin induced diabetes. Kidney Int 1992;41:768–777.
3.
Brito PL, Fioretto P, Drummond K, Kim Y, Steffes MW, Basgen JM, Sisson-Ross S, Mauer M: Proximal tubular basement membrane width in insulin-dependent diabetes mellitus. Kidney Int 1998;53:754–761.
4.
Frank J, Engler-Blum G, Roderman HP, Muller GA: Human renal tubular cells as a cytokine source: PDGF-B, GM-CSF and IL-6 mRNA expression in vitro. Exp Nephrol 1993;1:26–35.
5.
Phillips AO, Topley N, Steadman R, Morrisey K, Williams J: Induction of TGF-β1 synthesis in D-glucose primed human proximal tubular cells: Differential stimulation by the macrophage derived pro-inflammatory cytokines IL-1β and TNFα. Kidney Int 1996;50:1546–1554.
6.
Ong ACM, Fine LG: Tubular-derived growth factors and cytokines in the pathogenesis of tubulointerstitial fibrosis: Implications for human renal disease progression. Am J Kidney Dis 1994;23:205–209.
7.
Phillips AO, Morrisey R, Steadman R, Williams JD: Polarity of stimulation and secretion of TGF-β1 by proximal tubular cells. Am J Pathol 1997;150:1101–1111.
8.
Phillips AO, Steadman R, Topley N, Williams JD: Elevated D-glucose concentrations modulate TGF-β1 synthesis by human cultured renal proximal tubular cells: The permissive role of platelet derived growth factor. Am J Pathol 1995;147:362–374.
9.
Jovov B, Wills NK, Lewis AA: A spectroscopic method for assessing confluence of epithelial cell cultures. Am J Physiol 1991;262:C1196–C1203.
10.
Engval E: Fibronectin; in Bergmeyer HV (ed): Methods of Enzymatic Analysis. Weinheim, Verlag Chemie, 1986, pp 201–211.
11.
Donovan KL, Coles GA, Williams JD: An ELISA for the detection of type IV collagen in human urine: Application to patients with glomerulonephritis. Kidney Int 1994;46:1431–1437.
12.
Baker T, Tickle S, Wasan H, Docheerty A, Isenberg D, Waxman J: Serum metalloproteinases and their inhibitors: Markers for malignant potential. Br J Cancer 1994;70:506–512.
13.
Steadman R, Topley N, Jenner DE, Davies M, Williams JD: Type 1 fimbriate Escherichia coli stimulates a unique pattern of degranulation by human polymorphonuclear leukocytes. Infect Immun 1988;56:815–822.
14.
Martin J, Knowlden J, Davies M, Williams JD: Identification and independent regulation of human mesangial cell metalloproteinases. Kidney Int 1994;46:877–885.
15.
Maniatis T, Fritsch E, Sambrook J: Extraction, purification, and analysis of mRNA from eukaryotic cells; in Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, Cold Spring Harbor Press, 1987.
16.
O’Bryan JP, Frye RA, Cogswell PC, Neubauer A, Kitch B, Prokop C, Espinoza R, Le BM, Earp HS, Liu ET: A transforming gene isolated from primary human myeloid cells encodes a novel receptor tyrosine kinase. Mol Cell Biol 1991;11:5016–5031.
17.
Brinker JM, Gudas LJ, Loidl HR, Wang SY, Rosenbloom J, Kefalides NA, Myers JC: Restricted homology between human alpha-1 type IV and other procollagen chains. Proc Natl Acad Sci USA 1985;82:3649–3653.
18.
Bernard MP, Kolbe M, Weil D, Chu ML: Human cellular fibronectin: Comparison of the carboxyl-terminal portion with rat identifies primary structural domains separated by hypervariable regions. Biochemistry 1995;24:2698–2704.
19.
Collier TE, Scott MW, Eisen AZ, Marmer BL, Grant GA, Goldberg GI: H-ras oncogene-transformed human bronchial epithelial cells secrete a single metalloproteinase capable of degrading basement membrane collagen. J Biol Chem 1988;263:6569–6587.
20.
Docherty AJP, Lyons A, Smith BJ, Wright EM, Stephens PE, Harris TJR: Sequence of human tissue inhibitor of metalloproteinases and its identity to erythroid-potentiating activity. Nature 1985;318:66–69.
21.
Stetler-Stevenson WG, Brown PD, Onista M, Levy AT, Liotta LA: Tissue inhibitor of metalloproteinase-2 (TIMP-2) mRNA expression in tumour cell lines and human tumor tissues. J Biol Chem 1990;265:13933–13938.
22.
Neubauer A, Neubauer B, Liu E: Polymerase chain reaction based assay to detect allelic loss in human DNA: Loss of beta interferon gene in chronic myelogeneous leukemia. Nucleic Acids Res 1990;18:993–998.
23.
Pagtalunan ME, Millar PL, Eagle SJ, Nelson RG, Myers BD, Rennke HG, Coplon NS, Sun L, Meyer TW: Podocyte loss and progressive glomerular injury in type 2 diabetes. J Clin Invest 1997;99:342–348.
24.
Cagliero E, Maiello M, Boeri D, Roy S, Lorenzi M: Increased expression of basement components in human endothelial cells cultured in high glucose. J Clin Invest 1988;82:735–738.
25.
Cagliero E, Roth T, Maiello M, Lorenzi M: Expression of genes related to the extracellular matrix in human endothelial cells. J Biol Chem 1991;266:14244–14250.
26.
Cagiero E, Roth T, Roy S, Lorenzi M: Characteristics and mechanisms of high-glucose induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes 1991;40:102–110.
27.
Danne T, Spiro MJ, Spiro RG: Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells. Diabetes 1993;42:170–177.
28.
Roy S, Sala R, Cagliero E, Lorenzi M: Overexpression of fibronectin induced by diabetes or high glucose: Phenomenon with a memory. Proc Natl Acad Sci USA 1990;87:404–408.
29.
Nahman NS, Leonharat KL, Cosio FG, Hebert CL: Effects of high glucose on cellular proliferation and fibronectin production by cultured human mesangial cells. Kidney Int 1992;41:396–402.
30.
Poulsom R, Kurkinen M, Prokop D, Boot-Handford R: Increased steady-state levels of laminin B1 mRNA in kidneys of long-term streptozotoxin-diabetic rats. J Biol Chem 1986;263:10072–10076.
31.
Stetler-Stevenson WG: Dynamics of matrix turnover during pathologic remodeling of the extracellular matrix. Am J Pathol 1996;148:1345–1350.
32.
Cohen MP, Surma ML, Wu VY: In vivo biosynthesis and turnover of glomerular basement membrane in diabetic rats. Am J Physiol 1982;242:F385–F389.
33.
Beyer-Mears A, Ku L, Cohen MP: Glomerular polyol accumulation on diabetes and its prevention by oral sorbinil. Diabetes 1984;33:604–607.
34.
Bleyer AJ, Fumo P, Snipes ER, Goldfarb S, Simmons DA, Ziyadeh FN: Polyol pathway mediates high glucose induced collagen synthesis in proximal tubule. Kidney Int 1994;45:659–666.
35.
Mower P, Aynedjiam H, Silverman S, Wilkes B, Bank N: Sorbinil prevents glomerular hyper-perfusion in diabetic rats. Kidney Int 1989;35:433.
36.
Larkins RG, Dunlop ME: The link between hyperglycaemia and diabetic nephropathy. Diabetologia 1992;35:499–504.
37.
Williamson JR, Chang K, Frangos M, Hasan KS, Ido Y, Kawamura T, Nyengaard JR, Enden M, Kilo C, Tilton RG: Hyperglycaemia pseudohypoxia and diabetic complications. Diabetes 1993;42:801–813.
38.
Ruderman NB, Williamson JR, Brownlee M: Glucose and diabetic vascular disease. FASEB J 1992;6:2905–2914.
39.
Tilton RG, Baier LD, Harlow JE, Smith SR, Ostrow E, Williamson JR: Diabetes-induced glomerular dysfunction: Links to a more reduced cytosolic ratio of NADH/NAD. Kidney Int 1992;41:778–788.
40.
Phillips AO, Morrisey K, Martin J, Williams JD, Steadman R: Exposure of human renal proximal tubular cells to glucose leads to accumulation of type IV collagen and fibronectin by decreased degradation. Kidney Int 1997;52:973–984.
41.
Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schlericher ED: High glucose induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 1998;101:160–169.
42.
Craven PA, DeRubertis FR: Protein kinase is activated in glomeruli from streptozotocin diabetic rats. J Clin Invest 1989;83:1667–1675.
43.
Wolf BA, Williamson JR, Eason RA, Chang K, Sherman WR, Turk J: Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels. J Clin Invest 1991;87:31–38.
44.
Brand KA, Hermfisse U: Aerobic glycolysis by proliferating cells: A protective strategy against reactive oxygen species. FASEB J 1997;11:388–395.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.